Literature DB >> 21540291

Toll-like receptor-initiated testicular innate immune responses in mouse Leydig cells.

Tao Shang1, Xiaoyan Zhang, Tao Wang, Bing Sun, Tingting Deng, Daishu Han.   

Abstract

The testis is an immunoprivileged site, where the local cell-initiated testicular innate immune responses play a crucial role in defense against microbial infections. Mechanisms modulating the testicular cell-built defense system remain to be clarified. In this article, we demonstrate that Leydig cells, a major cell population in the testicular interstitium, initiate innate immunity through the activation of Toll-like receptors (TLRs). Several TLRs are expressed in mouse Leydig cells; among these, TLR3 and TLR4 are expressed at relatively high levels compared with other TLR members. Both TLR3 and TLR4 can be activated by their agonists (polyinosinic:polycytidylic acid and lipopolysaccharide) in Leydig cells and subsequently induce the production of inflammatory factors, such as IL-1β, IL-6, TNF-α, and type 1 interferons (IFN) (IFN-α and IFN-β). Notably, the activation of TLR3 and TLR4 suppresses steroidogenesis by Leydig cells. Further, we provide evidence that Axl and Mer receptor tyrosine kinases are expressed in Leydig cells and regulate TLR-mediated innate immune responses negatively. Data presented here describe a novel function of Leydig cells in eliciting testicular innate immune responses that should contribute to the protection of the testis from microbial infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540291     DOI: 10.1210/en.2011-0031

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age.

Authors:  Kelton Tremellen; Natalie McPhee; Karma Pearce; Sven Benson; Manfred Schedlowski; Harald Engler
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-11-28       Impact factor: 4.310

2.  Estrogen promotes Leydig cell engulfment by macrophages in male infertility.

Authors:  Wanpeng Yu; Han Zheng; Wei Lin; Astushi Tajima; Yong Zhang; Xiaoyan Zhang; Hongwen Zhang; Jihua Wu; Daishu Han; Nafis A Rahman; Kenneth S Korach; George Fu Gao; Ituro Inoue; Xiangdong Li
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 3.  Testicular defense systems: immune privilege and innate immunity.

Authors:  Shutao Zhao; Weiwei Zhu; Shepu Xue; Daishu Han
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

4.  Mice lacking Axl and Mer tyrosine kinase receptors are susceptible to experimental autoimmune orchitis induction.

Authors:  Nan Li; Zhenghui Liu; Yue Zhang; Qiaoyuan Chen; Peng Liu; C Yan Cheng; Will M Lee; Yongmei Chen; Daishu Han
Journal:  Immunol Cell Biol       Date:  2014-11-18       Impact factor: 5.126

5.  RIG-I-like receptors mediate innate antiviral response in mouse testis.

Authors:  Weiwei Zhu; Qiaoyuan Chen; Keqin Yan; Zhenghui Liu; Nan Li; Xiaoyan Zhang; Lili Yu; Yongmei Chen; Daishu Han
Journal:  Mol Endocrinol       Date:  2013-07-02

6.  Oxidant-Sensitive Inflammatory Pathways and Male Reproductive Functions.

Authors:  Sulagna Dutta; Pallav Sengupta; Srikumar Chakravarthi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Immunologic Environment of the Testis.

Authors:  Maolei Gong; Daishu Han
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Testisimmune privilege - Assumptions versus facts.

Authors:  G Kaur; P Mital; J M Dufour
Journal:  Anim Reprod       Date:  2013-01       Impact factor: 1.807

9.  Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases.

Authors:  Nan Qi; Peipei Liu; Yue Zhang; Hui Wu; Yongmei Chen; Daishu Han
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

10.  Structural, cellular and molecular aspects of immune privilege in the testis.

Authors:  Nan Li; Tao Wang; Daishu Han
Journal:  Front Immunol       Date:  2012-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.